{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:31Z","timestamp":1787020471469,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12744-3","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:24:54Z","timestamp":1749029094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Economic burden of five common cancers in Iran: a systematic review of cost-of-illness with a focus on healthcare resource utilization"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6793-9184","authenticated-orcid":false,"given":"Kamran","family":"Irandoust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-9571","authenticated-orcid":false,"given":"Vahid","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1223-4528","authenticated-orcid":false,"given":"Jalal","family":"Arabloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-7638","authenticated-orcid":false,"given":"Azin","family":"Nahvijou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1989-5250","authenticated-orcid":false,"given":"Akram","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"10184","key":"12744_CR1","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(18)33197-0","volume":"393","author":"G Danaei","year":"2019","unstructured":"Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet. 2019;393(10184):1984\u20132005.","journal-title":"Lancet"},{"issue":"3","key":"12744_CR2","first-page":"309","volume":"47","author":"B Farhood","year":"2018","unstructured":"Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review Article. Iran J Public Health. 2018;47(3):309.","journal-title":"Iran J Public Health"},{"issue":"3","key":"12744_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"12744_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ijc.33574","volume":"149","author":"G Roshandel","year":"2021","unstructured":"Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: recent incidence trends and short\u2010term predictions of the future burden. Int J Cancer. 2021;149(3):594\u2013605.","journal-title":"Int J Cancer"},{"key":"12744_CR5","unstructured":"Global Burden of Disease Study 2021. (GBD 2021) Data Resources [Internet]. Institute for Health Metrics and Evaluation. 2021 [cited 2024]. Available from: https:\/\/vizhub.healthdata.org\/gbd-results\/."},{"issue":"8","key":"12744_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14737167.2024.2353727","volume":"24","author":"A Rezapour","year":"2024","unstructured":"Rezapour A, Gholampour H, Barzegar M, Irandoust K, Afshari S, Arabloo J, et al. Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2024;24(8):899\u2013922.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research."},{"issue":"2","key":"12744_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.31557\/APJCP.2023.24.2.489","volume":"24","author":"F Aminuddin","year":"2023","unstructured":"Aminuddin F, Bahari MS, Zainuddin NA, Hanafiah ANM, Hassan NZAM. The direct and indirect costs of Cancer among the Lower-Income group: estimates from a pilot and feasibility study. Asian Pac J cancer Prevention: APJCP. 2023;24(2):489.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"issue":"4","key":"12744_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327\u201337.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"12744_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA group** T. Preferred reporting items for systematic reviews and meta-analyses: T.e PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"12744_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1332\/174426410X482999","volume":"6","author":"I Shemilt","year":"2010","unstructured":"Shemilt I, James T, Marcello M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6(1):51\u20139.","journal-title":"Evid Policy"},{"key":"12744_CR11","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"OHR Institute","year":"2019","unstructured":"Institute OHR. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. OHRI Ottawa; 2019."},{"key":"12744_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40258-020-00619-z","volume":"19","author":"N Iragorri","year":"2021","unstructured":"Iragorri N, de Oliveira C, Fitzgerald N, Essue B. The indirect cost burden of cancer care in Canada: a systematic literature review. Appl Health Econ Health Policy. 2021;19:325\u201341.","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"12744_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40273-021-01121-7","volume":"40","author":"M Huang","year":"2022","unstructured":"Huang M, Haiderali A, Fox GE, Frederickson A, Cortes J, Fasching PA, et al. Economic and humanistic burden of triple-negative breast cancer: a systematic literature review. PharmacoEconomics. 2022;40(5):519\u201358.","journal-title":"PharmacoEconomics"},{"issue":"11","key":"12744_CR14","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/pon.5516","volume":"29","author":"BM Essue","year":"2020","unstructured":"Essue BM, Iragorri N, Fitzgerald N, de Oliveira C. The psychosocial cost burden of cancer: A systematic literature review. Psycho-oncology. 2020;29(11):1746\u201360.","journal-title":"Psycho-oncology"},{"issue":"1","key":"12744_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12961-021-00732-y","volume":"19","author":"J Kazibwe","year":"2021","unstructured":"Kazibwe J, Tran PB, Annerstedt KS. The household financial burden of non-communicable diseases in low-and middle-income countries: a systematic review. Health Res Policy Syst. 2021;19(1):96.","journal-title":"Health Res Policy Syst"},{"issue":"3","key":"12744_CR16","first-page":"13","volume":"5","author":"A Imani","year":"2014","unstructured":"Imani A, Janati A, Gholipoor K, Ghoddousinejad J. Analysis and Estimation of the direct and indirect costs of breast cancer in women attending Shahid Ghazi clinic, Tabriz, 2013. Depiction Health. 2014;5(3):13\u20139.","journal-title":"Depiction Health"},{"key":"12744_CR17","unstructured":"Akbarzadeh BA, Esmaeili M, Kimiafar K. Medical information management and assessment of direct costs of treatment of lung cancer. Health Inf Manage. 2008;5(2):168."},{"key":"12744_CR18","unstructured":"Haghighat S, Akbari ME. Ghaffari S, Yavari P. Health expenditure in initial diagnostic and treatment approach to non-metastatic breast cancer in Iran. Iran J Breast Dis. 2013;6(2):14\u201325."},{"issue":"1","key":"12744_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12962-023-00470-8","volume":"21","author":"FS Jalali","year":"2023","unstructured":"Jalali FS, Keshavarz K, Seif M, Akrami M, Jafari A, Ravangard R. Economic burden of breast cancer: a case of Southern Iran. Cost Eff Resour Alloc. 2023;21(1):58.","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"12744_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12913-021-06136-6","volume":"21","author":"A Afkar","year":"2021","unstructured":"Afkar A, Jalilian H, Pourreza A, Mir H, Sigaroudi AE, Heydari S. Cost analysis of breast cancer: a comparison between private and public hospitals in Iran. BMC Health Serv Res. 2021;21(1):219.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"12744_CR21","first-page":"1225","volume":"44","author":"R Daroudi","year":"2015","unstructured":"Daroudi R, Sari AA, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K. The economic burden of breast cancer in Iran. Iran J Public Health. 2015;44(9):1225\u201333.","journal-title":"Iran J Public Health"},{"issue":"7","key":"12744_CR22","first-page":"748","volume":"4","author":"M Davari","year":"2013","unstructured":"Davari M, Yazdanpanah F, Aslani A, Hosseini M, Nazari AR, Mokarian F. The direct medical costs of breast Cancer in Iran: analyzing the patient\u2019s level data from a Cancer specific hospital in Isfahan. Int J Prev Med. 2013;4(7):748\u201354.","journal-title":"Int J Prev Med"},{"key":"12744_CR23","doi-asserted-by":"publisher","first-page":"107327482110099","DOI":"10.1177\/10732748211009952","volume":"28","author":"A Jafari","year":"2021","unstructured":"Jafari A, Alamdarloo PM, Dehghani M, Bastani P, Ravangard R. Economic burden of colorectal cancer: A case of Fars, Iran. Cancer Control. 2021;28:10732748211009952.","journal-title":"Cancer Control"},{"issue":"9","key":"12744_CR24","first-page":"1887","volume":"50","author":"M Nejati","year":"2021","unstructured":"Nejati M, Razavi M, Harirchi I, Zanganeh M, Salari G, Tabatabaee SM. Resource use and costs associated to the initial phase of treatment for patients with colorectal cancer receiving post-surgery chemotherapy: a cost analysis from a healthcare perspective. Iran J Public Health. 2021;50(9):1887\u201396.","journal-title":"Iran J Public Health"},{"issue":"1","key":"12744_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.14196\/mjiri.31.115","volume":"31","author":"Z Vahdatimanesh","year":"2017","unstructured":"Vahdatimanesh Z, Zendehdel K, Sari AA, Farhan F, Nahvijou A, Delavari A, et al. Economic burden of colorectal cancer in Iran in 2012. Med J Islamic Repub Iran. 2017;31(1):768\u201373.","journal-title":"Med J Islamic Repub Iran"},{"issue":"12","key":"12744_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.4103\/2008-7802.104861","volume":"3","author":"M Davari","year":"2012","unstructured":"Davari M, Maracy MR, Emami MH, Taheri D, Aslani A, Givi M, et al. The direct medical costs of colorectal Cancer in Iran; analyzing the patient\u2019s level data from a Cancer specific hospital in Isfahan. Int J Prev Med. 2012;3(12):887\u201392.","journal-title":"Int J Prev Med"},{"issue":"1","key":"12744_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12962-023-00493-1","volume":"21","author":"F Alinezhad","year":"2023","unstructured":"Alinezhad F, Khalili F, Zare H, Lu CL, Mahmoudi Z, Yousefi M. Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis. Cost Effect Resour Alloc. 2023;21(1):9.","journal-title":"Cost Effect Resour Alloc"},{"issue":"2","key":"12744_CR28","first-page":"139","volume":"10","author":"MJ Foroughi Moghadam","year":"2019","unstructured":"Foroughi Moghadam MJ, Ayati M, Rangchian M, Pourmand G, Haddad P, Nikoofar A, et al. Economic burden of prostate cancer in Iran: measuring costs and quality of life. Middle East J Cancer. 2019;10(2):139\u201355.","journal-title":"Middle East J Cancer"},{"issue":"1","key":"12744_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinthera.2018.11.001","volume":"41","author":"MM Mojahedian","year":"2019","unstructured":"Mojahedian MM, Toroski M, Keshavarz K, Aghili M, Zeyghami S, Nikfar S. Estimating the cost of illness of prostate Cancer in Iran. Clin Ther. 2019;41(1):50\u20138.","journal-title":"Clin Ther"},{"issue":"4","key":"12744_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1108\/IJPHM-12-2018-0061","volume":"13","author":"H Jalilian","year":"2019","unstructured":"Jalilian H, Doshmangir L, Ajami S, Mir H, Siraneh Y, Hasanpoor E. Economic burden of gastric cancer in the first six months after diagnosis. Int J Pharm Healthc Mark. 2019;13(4):436\u201346.","journal-title":"Int J Pharm Healthc Mark"},{"key":"12744_CR31","doi-asserted-by":"crossref","unstructured":"Eghdami A, Ostovar R, Jafari A, Palmer AJ, Bordbar N, Ravangard R. Economic burden of gastric cancer: a case study of Iran. Cancer Control. 2019;26(1):1\u20136.","DOI":"10.1177\/1073274819837185"},{"issue":"6","key":"12744_CR32","first-page":"3007","volume":"17","author":"A Izadi","year":"2016","unstructured":"Izadi A, Sirizi MJ, Esmaeelpour S, Barouni M. Evaluating direct costs of gastric Cancer treatment in Iran - Case study in Kerman City in 2015. Asian Pac J Cancer Prev. 2016;17(6):3007\u201313.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"12744_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1108\/IJPHM-08-2019-0055","volume":"14","author":"H Mir","year":"2020","unstructured":"Mir H, Seyednejad F, Jalilian H, Nosratnejad S, Yousefi M. Cost of lung cancer in East Azerbaijan Province, in Iran, in 2017. Int J Pharm Healthc Mark. 2020;14(3):461\u201370.","journal-title":"Int J Pharm Healthc Mark"},{"issue":"10","key":"12744_CR34","first-page":"4729","volume":"17","author":"S Rezaei","year":"2016","unstructured":"Rezaei S, Sari AA, Woldemichael A, Soofi M, Kazemi A, Matin BK. Estimating the economic burden of lung Cancer in Iran. Asian Pac J Cancer Prev. 2016;17(10):4729\u201333.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"12744_CR35","first-page":"1013","volume":"12","author":"MA Mohagheghi","year":"2011","unstructured":"Mohagheghi MA, Mousavi-Jarrahi Y, Mosavi-Jarrahi A. Cost of care for lung cancer in the first year after diagnosis in Iran. Asian Pac J Cancer Prev. 2011;12(4):1013\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"12744_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/jehp.jehp_928_21","volume":"12","author":"A Jabbari","year":"2023","unstructured":"Jabbari A, Hadian M, Mazaheri E, Jelodar ZK. The economic cost of cancer treatment in Iran. J Educ Health Promot. 2023;12:32.","journal-title":"J Educ Health Promot"},{"key":"12744_CR37","doi-asserted-by":"crossref","unstructured":"Mirmohammadkhani M, Ghahremanfard F, Tayyebi K, Ghadamgahi HB. Early direct costs of diagnostic and therapeutic services for patients with cancer: a descriptive study in Semnan, Iran, 2011\u20132014. Middle East J Rehabilitation Health Stud. 2019;6(1):e55457.","DOI":"10.5812\/mejrh.55457"},{"key":"12744_CR38","unstructured":"Bahmei J, Rahimi H, JAFARI AS, Habibyan M. Examination of medical and non-medical direct costs of outpatients and hospitalized cancer patients in Shiraz, Iran. Payesh. 2015;14(6):629\u201337."},{"key":"12744_CR39","unstructured":"Bazyar M, Pourreza A, Harirchi I, Akbari F, Mahmoudi M. Medical and non-medical direct costs of cancers in patients hospitalized in Imam Khomeini cancer institution-2010. jhosp. 2012;11(1):39\u201350."},{"key":"12744_CR40","unstructured":"Noori MF, Naieni KH, Haghdoost A, Emami A. Cost analysis for cancer subgroups in Kerman, Iran. Iran J Epidemiol. 2012;8(1):62\u201370."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12744-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:25:01Z","timestamp":1749029101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12744-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12744"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12744-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Iran University of Medical Sciences approved this review (Ref: IR.IUMS.REC.1402.549).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"800"}}